Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/54668, first published .
Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study)

Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study)

Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study)

Yuanchao Ma   1, 2, 3, 4 , MSc ;   Sofiane Achiche   1 , PhD ;   Marie-Pascale Pomey   5, 6, 7 , MD, PhD ;   Jesseca Paquette   5 , MSc ;   Nesrine Adjtoutah   5, 6 , MSc ;   Serge Vicente   2, 3, 8, 9 , PhD ;   Kim Engler   2, 3 , PhD ;   MARVIN chatbots MARVIN chatbots Patient Expert Committee   2, 10 ;   Moustafa Laymouna   2, 3, 8 , MD, MSc ;   David Lessard   2, 3, 4 , PhD ;   Benoît Lemire   4 , MSc ;   Jamil Asselah   11 , MD ;   Rachel Therrien   5 , MSc ;   Esli Osmanlliu   2, 12 , MD ;   Ma'n H Zawati   13 , PhD ;   Yann Joly   13 , PhD ;   Bertrand Lebouché   2, 3, 4, 8 , MD, PhD

1 Department of Biomedical Engineering, Polytechnique Montréal, Montreal, QC, Canada

2 Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada

3 Infectious Diseases and Immunity in Global Health Program, Research Institute of McGill University Health Centre, Montreal, QC, Canada

4 Chronic Viral Illness Service, Division of Infectious Disease, Department of Medicine, McGill University Health Centre, Montreal, QC, Canada

5 Research Centre of the University of Montreal Hospital Centre, Montreal, QC, Canada

6 Department of Health Policy, Management and Evaluation, School of Public Health, University of Montreal, Montreal, QC, Canada

7 Centre of Excellence on Partnership with Patients and the Public, Montreal, QC, Canada

8 Department of Family Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada

9 Department of Mathematics and Statistics, University of Montreal, Montreal, QC, Canada

10 See Acknowledgements, Montreal, QC, Canada

11 Department of Medicine, Division of Medical Oncology, McGill University Health Centre, Montreal, QC, Canada

12 Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, QC, Canada

13 Centre of Genomics and Policy, McGill University, Montreal, QC, Canada

Corresponding Author:

  • Bertrand Lebouché, MD, PhD
  • Chronic Viral Illness Service
  • Division of Infectious Disease, Department of Medicine
  • McGill University Health Centre
  • 1001 Decarie Blvd
  • Montreal, QC, H4A 3J1
  • Canada
  • Phone: 1 514 843 2090
  • Email: bertrand.lebouche@mcgill.ca